Compugen Ltd SEC filings CGEN
Compugen Ltd has 607 filings in SEC EDGAR's recent list, going back to Feb 13, 2001. Its latest annual report, Form 20-F, was filed on Mar 2, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Sep 10, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Jul 30, 2026 | Jul 29, 2026 |
| 4 | Insider transaction | Jul 30, 2026 | Jul 29, 2026 |
| 4 | Insider transaction | Jul 30, 2026 | Jul 29, 2026 |
| 4 | Insider transaction | Jul 30, 2026 | Jul 29, 2026 |
| 4 | Insider transaction | Jul 30, 2026 | Jul 29, 2026 |
| 4 | Insider transaction | Jul 30, 2026 | Jul 29, 2026 |
| 4 | Insider transaction | Jul 30, 2026 | Jul 29, 2026 |
| 4 | Insider transaction | Jul 30, 2026 | Jul 29, 2026 |
| 4 | Insider transaction | Jul 30, 2026 | Jul 29, 2026 |
| 4 | Insider transaction | Jul 30, 2026 | Jul 29, 2026 |
| 4 | Insider transaction | Jul 30, 2026 | Jul 29, 2026 |
| 4 | Insider transaction | Jul 30, 2026 | Jul 29, 2026 |
| 4 | Insider transaction | Jul 13, 2026 | Jul 9, 2026 |
| 4 | Insider transaction | Apr 27, 2026 | Apr 24, 2026 |
| 4 | Insider transaction | Apr 27, 2026 | Apr 24, 2026 |
| 144 | Notice of proposed sale | Apr 27, 2026 | — |
| 144 | Notice of proposed sale | Apr 27, 2026 | — |
| 4 | Insider transaction | Apr 15, 2026 | Apr 14, 2026 |
| 4 | Insider transaction | Apr 15, 2026 | Apr 14, 2026 |
| 4/A | Form 4/a | Apr 15, 2026 | Apr 10, 2026 |
| 144 | Notice of proposed sale | Apr 15, 2026 | — |
| 144 | Notice of proposed sale | Apr 15, 2026 | — |
| 4 | Insider transaction | Apr 13, 2026 | Apr 7, 2026 |
| 144 | Notice of proposed sale | Apr 13, 2026 | — |
| 4 | Insider transaction | Apr 9, 2026 | Apr 7, 2026 |
| 4 | Insider transaction | Apr 3, 2026 | Apr 1, 2026 |
| 4 | Insider transaction | Apr 3, 2026 | Apr 1, 2026 |
| 144 | Notice of proposed sale | Apr 2, 2026 | — |
| 4 | Insider transaction | Mar 30, 2026 | Mar 26, 2026 |
| 144 | Notice of proposed sale | Mar 26, 2026 | — |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 10, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 3, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 9, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 4, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Nov 19, 2021 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 16, 2021 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 11, 2021 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 5, 2021 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Oct 9, 2020 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2020 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 12, 2020 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 12, 2020 | — |
| SC 13G | Ownership over 5% (passive) | Sep 9, 2019 | — |
| SC 13G | Ownership over 5% (passive) | Sep 6, 2019 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2019 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2019 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 17, 2019 | — |
| SC 13G | Ownership over 5% (passive) | Jun 22, 2018 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2018 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2017 | — |
| SC 13G | Ownership over 5% (passive) | Feb 1, 2017 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 27, 2015 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2014 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Mar 21, 2013 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2013 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Aug 9, 2012 | — |
| SC 13G | Ownership over 5% (passive) | Mar 12, 2012 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2012 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 10, 2012 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2011 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 11, 2011 | — |
| SC 13D | Ownership over 5% (active) | May 26, 2010 | — |
| SC 13G | Ownership over 5% (passive) | Feb 12, 2010 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 12, 2010 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 12, 2010 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 12, 2010 | — |
| SC 13D/A | Amended ownership over 5% (active) | Jul 20, 2009 | — |
| SC 13D/A | Amended ownership over 5% (active) | Jul 1, 2009 | — |
| SC 13D/A | Amended ownership over 5% (active) | May 14, 2009 | — |
| SC 13D/A | Amended ownership over 5% (active) | Mar 30, 2009 | — |
| SC 13G | Ownership over 5% (passive) | Mar 10, 2009 | — |
| SC 13G | Ownership over 5% (passive) | Feb 13, 2009 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2009 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 10, 2009 | — |
| SC 13G | Ownership over 5% (passive) | Feb 10, 2009 | — |
| SC 13G | Ownership over 5% (passive) | Dec 22, 2008 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Dec 10, 2008 | — |
| SC 13D/A | Amended ownership over 5% (active) | Jul 31, 2008 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2008 | — |
| SC 13G | Ownership over 5% (passive) | May 7, 2007 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2007 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2006 | — |
| SC 13G | Ownership over 5% (passive) | Feb 6, 2006 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2005 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2005 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 17, 2004 | — |
| SC 13G | Ownership over 5% (passive) | Feb 17, 2004 | — |
| SC 13G | Ownership over 5% (passive) | Feb 10, 2004 | — |
| SC 13G | Ownership over 5% (passive) | Dec 10, 2003 | — |
| SC 13D | Ownership over 5% (active) | Jul 7, 2003 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2003 | — |
| SC 13G | Ownership over 5% (passive) | Dec 9, 2002 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2002 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2002 | — |
| SC 13G | Ownership over 5% (passive) | Feb 1, 2002 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2001 | — |
| SC 13G | Ownership over 5% (passive) | Feb 13, 2001 | — |
Showing 112 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CGEN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Holon, Israel
- SEC filer status
- Accelerated filer
- SEC CIK
- 1119774
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.